Unitaid transparency policy
Policy on ethics and conflict of interest for Unitaid
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Cervical cancer. Screening and treatment of pre-cancerous lesions for secondary prevention of cervical cancer
The state of the malaria RDT market 2018
Knowing your status – then and now. Realizing the potential of HIV self-testing, STAR Initiative Report
Intellectual property report on long-acting technologies
Market and technology landscape: HIV rapid diagnostic tests for self-testing, 4th edition
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2017 – 2021 Policy brief (May 2018)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2017 – 2021 Report (May 2018)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2017 – 2021 Policy brief (May 2018)
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
Impact story: Improving use of tuberculosis diagnostics
Impact story: Improving severe malaria outcomes
Impact story: Accelerating access to seasonal malaria chemoprevention
Impact story: HIV Self-Testing
Impact story: Improved treatment for HIV: Dolutegravir
Impact story: Early-infant diagnosis of HIV using point-of-care technologies
Impact story: Medicines Patent Pool
Impact story: Childhood tuberculosis
